360 High-Risk Vulnerability Immunization Tool V2.0 vs Glow: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Glow: Endpoint AI platform for software inventory, control, and safe AI adoption. built by Glow. Core capabilities include Continuous endpoint and software discovery, Automated asset inventory reconciliation and validation, Adaptable software control policies..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Glow differentiates with Continuous endpoint and software discovery, Automated asset inventory reconciliation and validation, Adaptable software control policies.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Glow is developed by Glow. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and Glow serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Patch Management. Review the feature comparison above to determine which fits your requirements.